Endocan as a marker of microvascular inflammation in kidney transplant recipients-Reference-Cited by-同舟云学术

Endocan as a marker of microvascular inflammation in kidney transplant recipients

Published:2019-02-12 Issue:1 Volume:9 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Lee Yu Ho,Kim Se-Yun,Moon Haena,Seo Jung-Woo,Kim Dong-Jin,Park Seon Hwa,Kim Yang-Gyun,Moon Ju-Young,Kim Jin Sug,Jeong Kyung-Hwan,Lim Sung-Jig,Kim Chan-Duck,Park Jae Berm,Chung Byung Ha^ORCID,Kim Yeong Hoon,Yang Jaeseok,Yang Hyung-In,Kim Kyoung Soo,Lee Sang-Ho

Funder

Ministry of Education, Science, and Technology

Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/s41598-018-37975-9.pdf

Reference53 articles.

1. Matas, A. J. et al. OPTN/SRTR 2013 Annual Data Report: kidney. American journal of transplantation: official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 15(Suppl 2), 1–34, https://doi.org/10.1111/ajt.13195 (2015).

2. Einecke, G. et al. Antibody-mediated microcirculation injury is the major cause of late kidney transplant failure. Am. J. Transplant. 9, 2520–2531, https://doi.org/10.1111/j.1600-6143.2009.02799.x (2009).